According to the well-known physics principle, an object in motion tends to stay in motion. That's been especially true at Cryoport over the past six months, as we’ve celebrated one big milestone after another. As we reach the halfway mark of 2019, we're committed to keep up the momentum. Here are our biggest headlines so far:
Cryoport Announces More Than $63M in Capital Raised to Support Company Mission
The company also announced public offering of common stock. Read more
Cryoport Team Rings Nasdaq Closing Bell
The same day, Cryoport’s stock reached an all-time high. See photos and watch the ceremony
Cryoport Acquires Cryogene, Expands into Biostorage
With the purchase of Cryogene Partners in Houston, Texas, we expanded our services to include biostorage. The 21,000-sq-ft facility covers the full range of temperatures and enables us to provide a much-requested option for our clients. Read more
Cryoport Announces 65% Revenue Growth in Q1 2019
The 65 percent revenue increase to $6.7 million was the result of new or expanded partnerships with Gilead, Novartus, Celularity, and Biokin Pharmaceuticals. Read more
Cryoport Publishes Pivotal Chain of Compliance™️ White Paper
Regulations are coming for the regenerative medicine industry – and soon. Research labs, pharmaceutical companies, and logistics providers need to prepare to adjust their operations as quickly as possible. Our white paper outlines the expected regulations and ways to prepare now. Read the white paper
Cryoport Partners with CalAmp to Develop Next Generation Condition Monitoring System
Global technology solutions provider CalAmp is working with Cryoport on an advanced supply chain monitoring system. “The solutions we are working with CalAmp to develop should, if successful, enable us to add offerings that will significantly reduce the risks associated with the temperature-controlled transportation of commodities in our markets,” said Cryoport CEO Jerrell Shelton. Read more
